|
New Metal Impurity Controls Coming, Pfizer Official Says
Draft International Conference on Harmonisation (ICH) guidance set for release in June will tighten regulatory controls on metal impurities in finished drug products, but drugmakers should begin analyzing planned and marketed products now, a Pfizer official urges.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Subscribe
Archives